Congenital adrenal hyperplasia classification: Difference between revisions
Jump to navigation
Jump to search
Replaced content with "{{Congenital adrenal hyperplasia}}" |
No edit summary |
||
Line 1: | Line 1: | ||
{{Congenital adrenal hyperplasia}} | {{Congenital adrenal hyperplasia}} | ||
==Classification== | |||
Congenital adrenal hyperplasia is classified into seven types based on the genetic causes that lead to hyperplasia and hormonal imbalance. | |||
{| align="center" class="wikitable" style="border: 0px; font-size: 90%; margin: 3px;" | |||
! align="center" style="background:#DCDCDC;" rowspan="2" colspan="2" |Disease | |||
! align="center" style="background:#DCDCDC;" colspan="2" |History and symptoms | |||
! align="center" style="background:#DCDCDC;" colspan="2" |Laboratory findings | |||
! align="center" style="background:#DCDCDC;" |Defective gene | |||
|- | |||
!Blood pressure | |||
!Genitalia | |||
! | |||
!K levels | |||
! | |||
|- | |||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" rowspan="2" |[[21-hydroxylase deficiency]] | |||
|Classic type | |||
| | |||
* Low in salt-wasting | |||
* Normal in non-salt-wasting | |||
| | |||
* Female: ambiguous | |||
* Male: normal or scrotal pigmentation and large phallus | |||
| | |||
Increased: | |||
* 17-OHP | |||
* Progesterone | |||
* Androstenedione | |||
* DHEA | |||
Decreased: | |||
* Aldosterone | |||
* Corticosterone (salt-wasting) | |||
* Cortisol (simple virilizing) | |||
| | |||
* High in salt wasting type | |||
* Normal in non salt wasting | |||
| | |||
* CYP21A1 and CYP21A2 gene | |||
|- | |||
|Non-classic type | |||
| | |||
* Normal | |||
| | |||
* Female: virilization after puberty | |||
* Male: normal appearance | |||
|Increased: | |||
* 17-OHP | |||
* Exaggerated androstene-dione, DHEA, and 17-OHP | |||
response to ACTH | |||
| | |||
* Normal | |||
| | |||
* CYP21A1 and CYP21A2 gene | |||
|- | |||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |17a-Hydroxylase deficiency | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Hypertension | |||
| | |||
* Female: normal | |||
* Male: ambiguous | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Increased DOC, corticosterone | |||
* Decreased 17OH-steroids, cortisol, aldosterone, androgens and estrogens | |||
| | |||
* Low | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
* ''CYP17A1'' | |||
|- | |||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |11β-hydroxylase deficiency | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Hypertension | |||
| | |||
* Female: ambiguous | |||
* Male: normal or scrotal pigmentation and large phallus | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Indreased DOC, 11-deoxycortisol | |||
* Decreased corticosterone, cortisol, aldosterone, androgens | |||
| | |||
* Low | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
* ''CYP11B1'' | |||
|- | |||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |3-beta-hydroxysteroid dehydrogenase | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
| | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Increased: | |||
* DHEA | |||
* 17-OH pregneno-lone | |||
* Pregnenolone | |||
Decreased: | |||
* Cortisol | |||
* Aldosterone | |||
| | |||
* High | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |Cytochrome P450-oxidoreductase (POR) deficiency (ORD) | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
| | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
| | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |Congenital lipoid adrenal hyperplasia | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
| | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
| | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |Cholesterol side-chain cleavage enzyme deficiency | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
| | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
| | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
|} |
Revision as of 15:58, 26 July 2017
Congenital adrenal hyperplasia main page |
Classification
Congenital adrenal hyperplasia is classified into seven types based on the genetic causes that lead to hyperplasia and hormonal imbalance.
Disease | History and symptoms | Laboratory findings | Defective gene | |||
---|---|---|---|---|---|---|
Blood pressure | Genitalia | K levels | ||||
21-hydroxylase deficiency | Classic type |
|
|
Increased:
Decreased:
|
|
|
Non-classic type |
|
|
Increased:
response to ACTH |
|
| |
17a-Hydroxylase deficiency |
|
|
|
|
| |
11β-hydroxylase deficiency |
|
|
|
|
| |
3-beta-hydroxysteroid dehydrogenase | Increased:
Decreased:
|
|
||||
Cytochrome P450-oxidoreductase (POR) deficiency (ORD) | ||||||
Congenital lipoid adrenal hyperplasia | ||||||
Cholesterol side-chain cleavage enzyme deficiency |